News|Articles|April 4, 2019

New Issue Alert: CURE Women's Cancers

Author(s)Katie Kosko, Brielle Benyon

Key Takeaways

Gynecologic cancer's psychosocial side effects are highlighted, emphasizing the need for comprehensive patient care beyond physical symptoms.
Ovarian cancer is increasingly viewed as a chronic disease, with new therapies enhancing patient survival and quality of life.
Primary Peritoneal Cancer, a rare ovarian cancer relative, is discussed, focusing on its signs, risks, and treatment options.
The link between the BRCA gene and hereditary cancers is explored, featuring insights from early BRCA family studies.

We've got a sneak peek at what’s inside CURE®'s Women’s Cancers issue.

Here’s a sneak peek at what’s inside our Women’s Cancers issue:

People are often vocal about cancer’s physical pain, but shy away when it comes to the disease’s psychosocial side effects. In our cover story, we are putting the unspoken side effects of gynecologic cancer Under the Spotlight.

Next, Ovarian Cancer’s New Identity. Oncologists are now looking at treating it like a chronic disease. Hear from four women and leading experts in the field as they discuss the newer therapies that are keeping patients alive.

And, learn about the rare relative of ovarian cancer. This feature helps patients understand the signs and risks of Primary Peritoneal Cancer and how the disease is treated.

Also, the BRCA gene and Hereditary Cancers go hand in hand. But how did researchers connect the two? Meet three sisters who were one of the first BRCA families studied.

To read these stories and more, visit curetoday.com/publications and click on the latest CURE® cover.

Or, ensure you don’t miss a story when you subscribe to new issue alerts. Visit curetoday.com/email-profile for more information.

And, as always, thanks for reading.